Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: India Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20121
20131
20141
20164
20172
20182
20194
20202
20215
20222
20239
20247
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status9
Recruiting7
Terminated5
Active, not recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Liver and Biliary Sciences, India11
Asian Institute of Gastroenterology, India3
Novartis Pharmaceuticals3
Novo Nordisk A/S3
89bio, Inc.2
Akero Therapeutics, Inc2
All India Institute of Medical Sciences, Bhubaneswar2
Gilead Sciences2
GlaxoSmithKline2
Medanta, The Medicity, India2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease43
Fatty Liver6
Diabetes Mellitus, Type 23
Fibrosis3
Liver Cirrhosis3
Liver Diseases3
Metabolic Syndrome3
Obesity3
Digestive System Diseases2
Hypothyroidism2

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.